1-9 of 9
Jonathan K. Kish, PhD MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Investigation of Spleen, Symptom, and Hematologic Response in Patients with Myelofibrosis Treated with First-Line Ruxolitinib

Jonathan K. Kish, PhD MPH, Arianna Kee, Pranav Abraham, Ronda Copher, PhD, Talia Miller, Aaron T. Gerds, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-136656
Published: 2020
Journal Articles

Real-World Utilization of Midostaurin Among Patients with Acute Myeloid Leukemia (AML)

Ajeet Gajra, MD FACP, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Dhruv Chopra, MS, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 5135.
https://doi.org/10.1182/blood-2019-130671
Published: 2019
Journal Articles

Persistence of Ruxolitinib Treatment in Patients with Myelofibrosis at Community Oncology Practices in the United States-Contemporary Data

Jingbo Yu, PhD, Jonathan K. Kish, PhD MPH, Dilan Paranagama, PhD, Philomena Colucci, DO, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5385.
https://doi.org/10.1182/blood-2019-123833
Published: 2019
Journal Articles

Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea

Ivy Altomare, MD, Anna Nguyen, PharmD, MPH, Shreekant Parasuraman, BPharm, PhD, Dilan Paranagama, PhD, Jonathan K. Kish, PhD MPH, Kevin Lord, PhD MHS, Philomena Colucci, DO, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4192.
https://doi.org/10.1182/blood-2019-127442
Published: 2019
Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 1952.
https://doi.org/10.1182/blood-2019-129593
Published: 2019
Journal Articles

Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma

Ajeet Gajra, MD FACP, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Jonathan K. Kish, PhD MPH, Bruce A Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 2198.
https://doi.org/10.1182/blood-2019-127741
Published: 2019
Journal Articles

Real-World Risk Assessment and Treatment of Patients with Myelofibrosis at Community Oncology Practices in the United States

Srdan Verstovsek, MD PhD, Jingbo Yu, PhD, Jonathan K. Kish, PhD MPH, Dilan Chamikara Paranagama, PhD, Jill Kaufman, Jessica Chung, PhD MPH, Michael R. Grunwald, MD, Philomena Colucci, DO, MS, Ruben A. Mesa, MD FACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1765.
https://doi.org/10.1182/blood-2018-99-115294
Published: 2018
Journal Articles

Cost-Effectiveness Comparison between Ibrutinib, Chemotherapy, and Chemoimmunotherapy in Front-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Chadi Nabhan, MD, Damion Nero, PhD, Choo Hyung Lee, MA, MS, Jonathan K. Kish, PhD MPH, Anthony R. Mato, MD MSCE
Journal: Blood
Blood (2018) 132 (Supplement 1): 4757.
https://doi.org/10.1182/blood-2018-99-118640
Published: 2018
Journal Articles

Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax (VEN) or Chemotherapy (CT)/Chemoimmunotherapy (CIT)

Chadi Nabhan, MD, Anthony R. Mato, MD MSCE, Jonathan K. Kish, PhD MPH, Damion Nero, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4758.
https://doi.org/10.1182/blood-2018-99-118904
Published: 2018